Reducing HIV replication with CRISPR could lead to effective cure

MIT HIV Vaccine
This human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. Image credit: National Institutes of Health

Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts two regulatory HIV-1 genes, tat and rev, which are essential for viral replication.

…

[W]hile lifelong antiretroviral therapy (ART) can help convert what is otherwise a deadly infection into a more “manageable chronic disease,” current treatments are not a cure because they can’t completely eradicate the virus, which inserts its genes into the host cells’ DNA, the authors explain. Despite treatment using ART, HIV-1 continues to replicate at a very low level in some latently infected immune system cell types, such as CD4+ cells, macrophages, and follicular dendritic cells. ”

…

The scientists generated six guide RNAs (gRNAs)—three targeting tat and three targeting rev—to direct the DNA-cleaving Cas9 enzyme to the relevant sites in the proviral DNA. They packaged gRNAs and the Cas9 enzyme system into a lentiviral vector, which they could then introduce into cultured cells.

…

They claim that the ability to transduce nondividing cells, such as resting CD4+ T cells, using lentiviral constructs and achieve long-term Cas9 transgene expression supports the feasibility of using the system to eradicate cells that act as latent reservoirs of HIV-1.

Editor’s note: Read full study

Read full, original post: CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures”

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
Crisp Physicians’ Protest Sign Close-Up
‘He’s a disgrace’: Some newly-elected legislators and health groups call for RFK Jr. impeachment 
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
ChatGPT-Image-Aug-18-2026-12_22_33-PM-2
‘The cure for measles is chicken soup and vitamin A’: Kennedy’s dangerous history of mocking vaccines
Split-Toned-Capitol-Healthcare-Rally
Viewpoint: Here’s how Congress can begin to reverse a two-year public health disinformation slide
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
Man in Green “Make America Healthy Again” Cap
Viewpoint: MAHA 2.0? Will the wellness grifters rescue RFK Jr.?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.